A Single- and Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2059 Powder for Inhalation

NCT07510958 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: SYH2059
DRUG: Placebo

Sponsor

InnovStone Therapeutics Limited